Prelude Therapeutics, Inc. (PRLD)
Prelude Therapeutics Market Cap : 258.48M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 258.48M |
| November 19, 2026 | 260.48M |
| November 18, 2026 | 264.09M |
| November 17, 2026 | 265.69M |
| November 16, 2026 | 272.89M |
| November 13, 2026 | 276.09M |
| November 12, 2026 | 281.69M |
| November 11, 2026 | 301.48M |
| November 10, 2026 | 299.89M |
| November 09, 2026 | 299.89M |
| November 06, 2026 | 287.13M |
| November 05, 2026 | 283.54M |
| November 04, 2026 | 325.41M |
| November 03, 2026 | 301.48M |
| November 02, 2026 | 306.27M |
| October 30, 2026 | 309.46M |
| October 29, 2026 | 327.00M |
| October 28, 2026 | 330.19M |
| October 27, 2026 | 309.46M |
| October 26, 2026 | 295.10M |
| October 23, 2026 | 289.52M |
| October 22, 2026 | 287.13M |
| October 21, 2026 | 291.11M |
| October 20, 2026 | 281.54M |
| October 19, 2026 | 270.38M |
| Date | Value |
|---|---|
| October 16, 2026 | 260.01M |
| October 15, 2026 | 264.79M |
| October 14, 2026 | 257.62M |
| October 13, 2026 | 283.94M |
| October 12, 2026 | 298.29M |
| October 09, 2026 | 310.26M |
| October 08, 2026 | 309.46M |
| October 07, 2026 | 305.47M |
| October 06, 2026 | 303.87M |
| October 05, 2026 | 300.68M |
| October 02, 2026 | 292.71M |
| October 01, 2026 | 302.28M |
| September 30, 2026 | 311.85M |
| September 29, 2026 | 315.84M |
| September 28, 2026 | 311.85M |
| September 25, 2026 | 309.06M |
| September 24, 2026 | 318.23M |
| September 23, 2026 | 343.75M |
| September 22, 2026 | 386.82M |
| September 21, 2026 | 374.86M |
| September 18, 2026 | 388.42M |
| September 17, 2026 | 364.49M |
| September 16, 2026 | 356.51M |
| September 15, 2026 | 360.50M |
| September 14, 2026 | 366.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Q32 Bio, Inc. | 249.30M |
| Intellia Therapeutics, Inc. | 1.403B |
| Twist Bioscience Corp. | 7.006B |
| Beam Therapeutics, Inc. | 2.162B |
| Revolution Medicines, Inc. | 34.86B |
Market Cap Related Metrics
| PS Ratio | 12.99 |
| Price to Book Value | 2.082 |
| Price | 3.23 |
| Earnings Yield | -20.14% |